Oxford Covishield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oxford covishield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oxford Covishield Today - Breaking & Trending Today

Covaxin phase 3 full trial data to be made public in July bharat biotech latest news


URL copied
Covaxin phase 3 full trial results will be made public in July. 
Covaxin phase 3 full trial results will be made public in July, Bharat Biotech informed on Wendesday. Covaxin is one of the three vaccines other than Oxford s Covishield and Russia s Sputnik V, that are being administered in India.
It is critical to understand and further emphasise the phase-3 data will first be submitted to Central Drugs Standard Control (CDSCO) followed by peer-reviewed journals, with a timeline of 3 months for publication, and as communicated earlier COVAXIN phase 3 results full trial data will be made public during July. Once data from the final analysis of phase III studies are available, Bharat Biotech will apply for full licensure for COVAXIN, Bharat Biotech informed ANI. ....

Oxford Covishield , Serum Institute Of India , Health Ministry , Image Source , Bharat Biotech , Central Drugs Standard Control , Serum Institute , Bharat Biotech , சீரம் நிறுவனம் ஆஃப் இந்தியா , ஆரோக்கியம் அமைச்சகம் , படம் மூல , பாரத் பயோடெக் , மைய மருந்துகள் தரநிலை கட்டுப்பாடு , சீரம் நிறுவனம் ,

Biocon founder Kiran Mazumdar Shaw hails expert panel's nod to Sputnik V


Biocon founder Kiran Mazumdar Shaw hails expert panel’s nod to Sputnik V
SECTIONS
Last Updated: Apr 13, 2021, 10:54 AM IST
Share
Synopsis
“It adds to our armoury. I hope it is one more step towards vaccinating the general population,” Shaw told ET on hearing the news about a third vaccine making its way into India. Health authorities in India are currently using Bharat Biotech’s Covaxin and Oxford’s Covishield to vaccinate eligible people.
Agencies
Biocon founder Kiran Mazumdar Shaw
Biocon founder Kiran Mazumdar-Shaw on Monday hailed the subject expert committee (SEC) clearing Russia’s Sputnik V vaccine for emergency use in India as yet another step forward in India’s fight against Covid-19. ....

Arun Chandavarkar , Oxford Covishield , Russia Direct Investment Fund , Electronics City , Kiran Mazumdar Shaw , Bharat Biotech , Drugs Controller General , Biocon Biologics , Drugs Controller General Of India , Sputnik V , Covid 19 , அருண் சாண்டவர்கள் , ரஷ்யா நேரடி முதலீடு நிதி , மின்னணுவியல் நகரம் , கிறன் மஜும்தர் ஷா , பாரத் பயோடெக் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , பயோகான் உயிரியல் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் ஆஃப் இந்தியா , ஸ்பட்நிக் வ் ,